Regeneus (ASX:RGS) has received US regulatory approval to commercialise a cell-based canine cancer vaccine in the US, giving it an accelerated pathway to launch. [ + ]

CellBank Australia is conducting a survey into the usage and anticipated demand for cell lines and cell culture services among Australian researchers. [ + ]

The 2013 Research Australia Awards, held last night at the Park Hyatt in Melbourne, recognised individuals and corporations for areas such as discovery, advocacy, philanthropy and lifetime achievement. [ + ]

The medical device segment was the star performer of the Australian life sciences sector during Q413, and the stage is set for further growth, PwC's latest BioForum report says. [ + ]

All animals have to make decisions every day - often as a group to help their survival. Researchers from Arizona State University, hoping to understand how the collective decision-making process arises out of individually ignorant ants, have conducted an experiment which found that the creatures can change their decision-making strategies based on experience. [ + ]

A joint venture between Novogen (ASX:NRT) and Yale University will focus on developing ovarian cancer drugs, eventually including personalised chemotherapeutic treatments. [ + ]

The investment that has been put into personalised medicine is starting to pay off - the tailored diagnosis, prognosis, treatment and prevention of disease in an individual is beginning to be applied, as David Randerson intends to explain at the conference. [ + ]

The UK delegation that attended the recent 2013 AusBiotech meeting is keen to develop its relationship with the Australian biotech sector. [ + ]

Mesoblast's partner Teva Pharmaceutical Industries has secured US FDA approval for a phase III IND trial of Mesoblast's MPCs in congestive heart failure. [ + ]

The European Institute of Oncology (IEO), an Italy-based organisation committed to fighting cancer - particularly tumours of the breast, lung, prostate and bowel - has implemented a new laboratory information management system (LIMS) to more efficiently manage its biospecimen data. [ + ]

Shares in Prana Biotechnology (ASX:PBT) climbed 43% after a scientific paper detailed how Alzheimer's drug candidate PBT2 reversed cognitive and memory loss in old mice. [ + ]

Hatchtech has raised $12.6m from existing and new investors to support its phase III trials and US NDA for DeOvo, a single-dose headlice treatment. [ + ]

Protego Medical, a company developing a device to protect the sternum during cardiac surgery, launched yesterday with $2m in MRCF seed funding. [ + ]

Brisbane yesterday welcomed the official launch of the AusBiotech 2013 national conference - a premier event on the Australia and Asia-Pacific calendar - recognising world-class leaders in the biotechnology industry with the Janssen Industry Excellence Awards. [ + ]

From mathematics and statistics, through electronics, quantum computing and defeating zombie ideas in ecology, to inspirational primary and high school teaching, this year's winners of the Prime Minister's Prize for Sciences show the depth of talent in the Australian science scene. [ + ]